These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 1771299

  • 1. Single and combination treatment with vitamin K3 and adriamycin: in vitro effects on cell survival and DNA damage in human chronic myeloid leukemia cells.
    Parekh H, Chavan S, Advani S, Chitnis M.
    Sel Cancer Ther; 1991; 7(3):127-35. PubMed ID: 1771299
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sensitization of chronic myeloid leukemia cells to adriamycin cytotoxicity by clofibrate.
    Parekh H, Satyamoorthy K, Advani S, Chitnis M.
    Tumori; 1990 Feb 28; 76(1):18-21. PubMed ID: 2321268
    [Abstract] [Full Text] [Related]

  • 8. Dipyrone enhances intracellular accumulation and cytotoxicity of adriamycin in human chronic myeloid leukemia cells.
    Chitnis MP, Kamath NS, Parekh HK, Advani SH.
    Neoplasma; 1991 Feb 28; 38(2):185-91. PubMed ID: 2041578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Amelioration of doxorubicin resistance by pentoxifylline in human chronic myeloid leukemia cells in vitro.
    Viladkar A, Juvekar A, Chitnis M, Advani S.
    Sel Cancer Ther; 1991 Feb 28; 7(3):119-26. PubMed ID: 1771298
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Costunolide enhances sensitivity of K562/ADR chronic myeloid leukemia cells to doxorubicin through PI3K/Akt pathway.
    Cai H, Li L, Jiang J, Zhao C, Yang C.
    Phytother Res; 2019 Jun 28; 33(6):1683-1688. PubMed ID: 30937974
    [Abstract] [Full Text] [Related]

  • 15. Modulation of mitoxantrone cytotoxicity by verapamil in human chronic myeloid leukemia cells.
    Satyamoorthy K, Chitnis MP, Pradhan SG, Advani SH.
    Oncology; 1989 Jun 28; 46(2):128-31. PubMed ID: 2710477
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T, Nieborowska-Skorska M, Wlodarski P, Perrotti D, Hoser G, Kawiak J, Majewski M, Christensen L, Iozzo RV, Calabretta B.
    J Natl Cancer Inst; 1997 Jan 15; 89(2):124-33. PubMed ID: 8998181
    [Abstract] [Full Text] [Related]

  • 17. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun 15; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 18. Interferon-alpha enhances the cytotoxic and cytostatic activities of chemotherapeutic drugs in human myeloid leukemia cells.
    Hassan HT, Grell S, Borrmann-Danso U, Freund M.
    J Interferon Cytokine Res; 1996 Feb 15; 16(2):139-46. PubMed ID: 8742366
    [Abstract] [Full Text] [Related]

  • 19. Genotoxic effect of doxorubicin-transferrin conjugate on human leukemia cells.
    Szwed M, Jozwiak Z.
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep 01; 771():53-63. PubMed ID: 25308442
    [Abstract] [Full Text] [Related]

  • 20. The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells.
    Rowley PT, Keng PC, Kosciolek BA.
    Leuk Res; 1996 Jun 01; 20(6):473-80. PubMed ID: 8709619
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.